Aerie Pharmaceuticals
AERI
$15.25
Share price
0.00%
Change (1 day)
83.73%
Change (1 year)
Categories
Operating Margin for Aerie Pharmaceuticals (AERI)
Operating Margin as of May 2024 (TTM): -10.86%
According to Aerie Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -10.86%. At the end of 2021 the company had an Operating Margin of -38.23%.
Operating Margin history for Aerie Pharmaceuticals from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -38.23% | -82.13% |
| 2020 | -213.93% | -25.12% |
| 2019 | -285.70% | -70.29% |
| 2018 | -961.77% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Merck MRK | 27.73% | -355.34% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | -87,620.60% | 806,719.52% | 🇺🇸 USA |
 Insmed INSM | -195.69% | 1,701.93% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.